Case closed: Neutrons settle 40-year debate on enzyme for drug design
Filter News
Area of Research
- (-) Computational Biology (1)
- Advanced Manufacturing (4)
- Biology and Environment (7)
- Clean Energy (19)
- Fuel Cycle Science and Technology (1)
- Fusion and Fission (27)
- Fusion Energy (10)
- Isotope Development and Production (1)
- Isotopes (3)
- Materials (68)
- Materials for Computing (5)
- National Security (10)
- Neutron Science (103)
- Nuclear Science and Technology (39)
- Nuclear Systems Modeling, Simulation and Validation (1)
- Quantum information Science (1)
- Supercomputing (25)
News Type
Date
Media Contacts
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.